Literature DB >> 28724151

Assessment of Addiction Medicine Training in Family Medicine Residency Programs: A CERA Study.

Sebastian Tong1, Roy Sabo, Rebecca Aycock, Ramakrishna Prasad, Rebecca Etz, Anton Kuzel, Alex Krist.   

Abstract

BACKGROUND AND OBJECTIVES: Substance use disorder (SUD) is a widespread problem but physicians may feel inadequately prepared to provide addiction care. We sought to assess current addiction medicine curricula in US family medicine residencies (FMRs) and evaluate barriers to improving or implementing addiction medicine curricula.
METHODS: Questions regarding addiction medicine training were added to the December 2015 Council of Academic Family Medicine Educational Research Alliance (CERA) survey to US FMR program directors to evaluate each FMR's curriculum, potential workforce production, perceived barriers to improving or implementing curricula and faculty training in addiction medicine.
RESULTS: Of 461 FMR directors, 227 (49.2%) responded; 28.6% reported a required addiction medicine curricula. Regional variations of having a required curriculum ranged from 41.3% in the Northeast to 20.0% in the South (P=0.07). Of residencies, 31.2% had at least one graduate obtain a buprenorphine prescription waiver in the past year and 8.6% had at least one graduate pursue an addiction medicine fellowship in the past 5 years. Lack of faculty expertise was the most commonly cited barrier to having a curriculum, with only 36.2% of programs having at least one buprenorphine waivered faculty member, 9.4% an addiction medicine board certified faculty, and 5.5% a fellowship trained faculty.
CONCLUSIONS: Few FMRs have addiction medicine curricula and most graduates do not seek additional training. Multifaceted efforts, including developing model national curricula, training existing faculty, and recruiting addiction trained faculty, may improve addiction medicine training in family medicine residencies to better address the growing SUD epidemic.

Entities:  

Mesh:

Year:  2017        PMID: 28724151

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  8 in total

1.  Chronic Opioid Prescribing in Primary Care: Factors and Perspectives.

Authors:  Sebastian T Tong; Camille J Hochheimer; E Marshall Brooks; Roy T Sabo; Vivian Jiang; Teresa Day; Julia S Rozman; Paulette Lail Kashiri; Alex H Krist
Journal:  Ann Fam Med       Date:  2019-05       Impact factor: 5.166

2.  Buprenorphine Provision by Early Career Family Physicians.

Authors:  Sebastian T Tong; Camille J Hochheimer; Lars E Peterson; Alex H Krist
Journal:  Ann Fam Med       Date:  2018-09       Impact factor: 5.166

3.  Teaching Safe Opioid Prescribing During the Opioid Epidemic: Results of the 2018 Clerkship Directors in Internal Medicine Survey.

Authors:  Mim Ari; Michael Kisielewski; Nora Y Osman; Karen Szauter; Clifford D Packer; Amber T Pincavage
Journal:  J Gen Intern Med       Date:  2019-07-31       Impact factor: 5.128

4.  Primary Care Implementation of a Mandatory Prescription Drug Monitoring Program in New York City.

Authors:  Rachel Chernick; Bennett Allen; Alex Harocopos
Journal:  J Behav Health Serv Res       Date:  2021-08-23       Impact factor: 1.475

Review 5.  COVID-19-related adaptations to the implementation and evaluation of a clinic-based intervention designed to improve opioid safety.

Authors:  Anna R Morgan; Michelle A Hendricks; Sanae El Ibrahimi; Sara E Hallvik; Brigit Hatch; Caitlin Dickinson; Dagan Wright; Michael A Fischer
Journal:  Drugs Context       Date:  2021-12-15

6.  Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors.

Authors:  Donna M Windish; Jillian S Catalanotti; Aimee Zaas; Michael Kisielewski; John P Moriarty
Journal:  J Gen Intern Med       Date:  2021-11-02       Impact factor: 6.473

7.  "Health Is on the Back Burner:" Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs.

Authors:  Delia Motavalli; Jessica L Taylor; Ellen Childs; Pablo K Valente; Peter Salhaney; Jennifer Olson; Dea L Biancarelli; Alberto Edeza; Joel J Earlywine; Brandon D L Marshall; Mari-Lynn Drainoni; Matthew J Mimiaga; Katie B Biello; Angela R Bazzi
Journal:  J Gen Intern Med       Date:  2020-09-11       Impact factor: 5.128

Review 8.  Identification and Management of Opioid Use Disorder in Primary Care: an Update.

Authors:  Joseph H Donroe; Elenore P Bhatraju; Judith I Tsui; E Jennifer Edelman
Journal:  Curr Psychiatry Rep       Date:  2020-04-13       Impact factor: 5.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.